Procter & Gamble Co. expands its US dietary supplement lineup with “nerve relief” products based on formulations it gained in its 2018 acquisition of Merck KGaAs consumer health business.
P&G is introducing its Nervive supplement line in the US after marketing the formulations under the brand Neurobion in Europe, Asia and Latin America since closing its deal with Merck...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?